Related Experiment Videos
Unaffordable cost of pharmaceuticals: a cause for suboptimal compliance
Journal of the American Geriatrics Society
|November 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Management of ruptured amoebic liver abscess: 22-years experience.
Journal of Ayub Medical College, Abbottabad : JAMC·2011
The Association Between Nursing Home Medical Directors and Care Quality: Evidence From Certified Medical Director Hires.
Journal of the American Geriatrics Society·2026
Cannabis Use Among People Aged 65 and Older: Results From an Intercept Survey in New York City.
Journal of the American Geriatrics Society·2026
Mobile Cardiac Rehabilitation for Older Adults With Ischemic Heart Disease: A 12-Month Follow-Up on Hospital Readmissions in the RESILIENT Trial.
Journal of the American Geriatrics Society·2026
Best Case/Worst Case: A Multisite Randomized Trial of Scenario Planning for Patients With Late-Stage Kidney Disease.
Journal of the American Geriatrics Society·2026
Direct-To-Home Tele-Neuropsychological Assessment in Older Adults: A Systematic Review.
Journal of the American Geriatrics Society·2026
Improving Oral Care in the Hospital: Program HOPE.
Journal of the American Geriatrics Society·2026
Mirogabalin, C12H19NO2, and mirogabalin besylate, C12H20NO2+·C6H5O3S.
Acta crystallographica. Section C, Structural chemistry·2026
What is in the bottle? An analysis of the ingredients in menopause supplements.
Climacteric : the journal of the International Menopause Society·2026
Non-Prescribed Gabapentinoid Use: Demographic and Behavioural Risk Profiles in a Large International Sample.
Drug and alcohol review·2026
Effects of intestinal permeation enhancers on solubilization and epithelial transport of the proteolysis targeting chimera (PROTAC) ARV-471 in rats.
Journal of controlled release : official journal of the Controlled Release Society·2026
Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines.
Clinical pharmacology and therapeutics·2026